ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

130
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Refresh
08 May 2020 14:41

Asia HY Monthly - Impact Of COVID-19 On Investment Strategy - Lucror Analytics

The global economic impact of COVID-19 deepened in April, with many countries now expected to see GDP contract in 2020. That said, credit and...

Logo
288 Views
Share
29 Apr 2020 15:31

Asia HY Trade Recommendations - April 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of April includes a summary of our recommendations. The report also features relative-value...

Logo
298 Views
Share
03 Apr 2020 16:32

Asia HY Monthly - COVID-19 And Oil Shock Update (March 2020) - Lucror Analytics

The spread of COVID-19 and, to a lesser degree, the oil price war between Russia and Saudi Arabia overshadowed most other issues in March. These...

Logo
303 Views
Share
bearishMedco Energi
24 Mar 2020 08:56

Morning Views Asia: Agility, Car Inc, Future Retail, Glenmark Pharmaceuticals, Medco Energi

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
258 Views
Share
23 Mar 2020 16:11

Asia HY Trade Recommendations - March 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for March 2020 includes a summary of our recommendations and high-conviction ideas. We also provide...

Logo
267 Views
Share
x